Cardia Bioplastics Limited
Myeco Group Ltd, together with its subsidiaries, develops, manufactures, and sells sustainable packaging materials in Oceanic, Asia, the United States, Europe, and Africa. The company supplies biodegradable and compostable resins, packaging products, and cast films to blue-chip companies. It manufactures and distributes polyethylene films, renewable resources resins, and finished products. The co… Read more
Cardia Bioplastics Limited (SCGRF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.019x
Based on the latest financial reports, Cardia Bioplastics Limited (SCGRF) has a cash flow conversion efficiency ratio of 0.019x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($440.50K) by net assets ($23.13 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cardia Bioplastics Limited - Cash Flow Conversion Efficiency Trend (2020–2023)
This chart illustrates how Cardia Bioplastics Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cardia Bioplastics Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cardia Bioplastics Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FARMACOSMO SPA O.N.
F:ZJ1
|
N/A |
|
Domo Activos Socimi SA
MC:DOMO
|
-0.026x |
|
Metalicity Limited
STU:P8O
|
-0.055x |
|
Freja eID Group AB
ST:FREJA
|
0.075x |
|
Van Phat Hung Corp
VN:VPH
|
N/A |
|
Willbes
KO:008600
|
0.151x |
|
Rigel Resource Acquisition Corp.
OTCGREY:RRACF
|
0.150x |
|
Tribeca Resources Corporation
PINK:TRRCF
|
-0.054x |
Annual Cash Flow Conversion Efficiency for Cardia Bioplastics Limited (2020–2023)
The table below shows the annual cash flow conversion efficiency of Cardia Bioplastics Limited from 2020 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-06-30 | $23.13 Million | $2.02 Million | 0.087x | +157.30% |
| 2022-06-30 | $26.67 Million | $-4.06 Million | -0.152x | +5.44% |
| 2021-06-30 | $29.22 Million | $-4.70 Million | -0.161x | -181.57% |
| 2020-06-30 | $11.38 Million | $-650.38K | -0.057x | -- |